A型肝炎不活化ワクチンの世界市場に関する洞察、2030年までの予測

当レポートは、A型肝炎不活化ワクチン (Hepatitis A Inactivated Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• A型肝炎不活化ワクチンの製品概要
• 市場：タイプ別
  • 世界のA型肝炎不活化ワクチンの市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
  • 25U/0.5ml
  • 50U/1.0ml
• 市場：用途別
  • 世界のA型肝炎不活化ワクチンの市場規模成長率：用途別, 2019 VS 2023 VS 2030
  • Hospital
  • Clinic
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界のA型肝炎不活化ワクチンの収益 推定および予測 2019-2030
• 世界のA型肝炎不活化ワクチンの収益：地域別
  • 世界のA型肝炎不活化ワクチンの収益：地域別: 2019 VS 2023 VS 2030
  • 世界のA型肝炎不活化ワクチンの収益：地域別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの収益：地域別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの収益市場シェア 地域別 (2019-2030)
• 世界のA型肝炎不活化ワクチン 売上予測・予想 2019-2030
• 世界のA型肝炎不活化ワクチンの販売：地域別
  • 世界のA型肝炎不活化ワクチンの販売：地域別: 2019 VS 2023 VS 2030
  • 世界のA型肝炎不活化ワクチンの販売：地域別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの販売：地域別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの販売市場シェア 地域別 (2019-2030)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界のA型肝炎不活化ワクチンの販売：企業別
  • 世界のA型肝炎不活化ワクチンの販売：企業別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの販売市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： A型肝炎不活化ワクチン in 2023
• 世界のA型肝炎不活化ワクチンの収益：企業別
  • 世界のA型肝炎不活化ワクチンの収益：企業別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの収益市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： A型肝炎不活化ワクチンの収益 2023
• 世界の主要企業 A型肝炎不活化ワクチン, 業界ランキング, 2021 VS 2022
• 世界のA型肝炎不活化ワクチンの販売価格：企業別 (2019-2024)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界のA型肝炎不活化ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー A型肝炎不活化ワクチン, 製造拠点分布と本社
• 世界の主要メーカー A型肝炎不活化ワクチン, 提供製品と用途
• 世界の主要メーカー A型肝炎不活化ワクチン, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界のA型肝炎不活化ワクチンの販売：タイプ別
  • 世界のA型肝炎不活化ワクチンの販売実績：タイプ別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの販売予測：タイプ別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの販売市場シェア：タイプ別 (2019-2030)
• 世界のA型肝炎不活化ワクチン 収益：タイプ別
  • 世界のA型肝炎不活化ワクチンの収益実績：タイプ別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの収益予測：タイプ別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの収益市場シェア：タイプ別 (2019-2030)
• 世界のA型肝炎不活化ワクチンの価格：タイプ別
  • 世界のA型肝炎不活化ワクチンの価格：タイプ別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

• 世界のA型肝炎不活化ワクチンの販売：用途別
  • 世界のA型肝炎不活化ワクチンの販売実績：用途別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの販売予測：用途別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの販売市場シェア：用途別 (2019-2030)
• 世界のA型肝炎不活化ワクチンの収益：用途別
  • 世界のA型肝炎不活化ワクチンの収益実績：用途別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの収益予測：用途別 (2025-2030)
  • 世界のA型肝炎不活化ワクチンの収益市場シェア：用途別 (2019-2030)
• 世界のA型肝炎不活化ワクチンの価格：用途別
  • 世界のA型肝炎不活化ワクチンの価格：用途別 (2019-2024)
  • 世界のA型肝炎不活化ワクチンの価格予測：用途別 (2025-2030)

第6章 米国・カナダ

• 米国・カナダ A型肝炎不活化ワクチン 市場規模：タイプ別
  • 米国・カナダ A型肝炎不活化ワクチンの販売：タイプ別 (2019-2030)
  • 米国・カナダ A型肝炎不活化ワクチン 収益：タイプ別 (2019-2030)
• 米国・カナダ A型肝炎不活化ワクチン 市場規模：用途別
  • 米国・カナダ A型肝炎不活化ワクチンの販売：用途別 (2019-2030)
  • 米国・カナダ A型肝炎不活化ワクチンの収益：用途別 (2019-2030)
• 米国・カナダ A型肝炎不活化ワクチン 市場規模：国別
  • 米国・カナダ A型肝炎不活化ワクチンの収益：国別: 2019 VS 2023 VS 2030
  • 米国・カナダ A型肝炎不活化ワクチンの収益：国別 (2019-2030)
  • 米国・カナダ A型肝炎不活化ワクチンの販売：国別 (2019-2030)
  • US
  • カナダ

第7章 欧州

• 欧州のA型肝炎不活化ワクチン 市場規模：タイプ別
  • 欧州のA型肝炎不活化ワクチンの販売：タイプ別 (2019-2030)
  • 欧州のA型肝炎不活化ワクチン 収益：タイプ別 (2019-2030)
• 欧州のA型肝炎不活化ワクチン 市場規模：用途別
  • 欧州のA型肝炎不活化ワクチンの販売：用途別 (2019-2030)
  • 欧州のA型肝炎不活化ワクチンの収益：用途別 (2019-2030)
• 欧州のA型肝炎不活化ワクチン 市場規模：国別
  • 欧州のA型肝炎不活化ワクチンの収益：国別: 2019 VS 2023 VS 2030
  • 欧州のA型肝炎不活化ワクチンの収益：国別 (2019-2030)
  • 欧州のA型肝炎不活化ワクチンの販売：国別 (2019-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国のA型肝炎不活化ワクチン 市場規模：タイプ別
  • 中国のA型肝炎不活化ワクチンの販売：タイプ別 (2019-2030)
  • 中国のA型肝炎不活化ワクチン 収益：タイプ別 (2019-2030)
• 中国のA型肝炎不活化ワクチン 市場規模：用途別
  • 中国のA型肝炎不活化ワクチンの販売：用途別 (2019-2030)
  • 中国のA型肝炎不活化ワクチンの収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 A型肝炎不活化ワクチン 市場規模：タイプ別
  • アジア地域 A型肝炎不活化ワクチンの販売：タイプ別 (2019-2030)
  • アジア地域 A型肝炎不活化ワクチン 収益：タイプ別 (2019-2030)
• アジア地域 A型肝炎不活化ワクチン 市場規模：用途別
  • アジア地域 A型肝炎不活化ワクチンの販売：用途別 (2019-2030)
  • アジア地域 A型肝炎不活化ワクチンの収益：用途別 (2019-2030)
• アジア地域 A型肝炎不活化ワクチン 市場規模：地域別
  • アジア地域 A型肝炎不活化ワクチンの収益：地域別: 2019 VS 2023 VS 2030
  • アジア地域 A型肝炎不活化ワクチンの収益：地域別 (2019-2030)
  • アジア地域 A型肝炎不活化ワクチンの販売：地域別 (2019-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチン 市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの販売：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチン 収益：タイプ別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチン 市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの販売：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの収益：用途別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチン 市場規模：国別
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの収益：国別: 2019 VS 2023 VS 2030
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの収益：国別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのA型肝炎不活化ワクチンの販売：国別 (2019-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• Pfizer
• Merck
• Sanofi
• GlaxoSmithKline
• Health Pharma
• Huakang Pharmaceutical
• Limin Pharmaceutical
• Xianghe Pharmaceutical

第12章 業界チェーンと販売チャネルの分析

• A型肝炎不活化ワクチン 業界チェーン分析
• A型肝炎不活化ワクチン 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• A型肝炎不活化ワクチン 生産形態とプロセス
• A型肝炎不活化ワクチン 販売およびマーケティング
  • A型肝炎不活化ワクチン 販売チャネルs
  • A型肝炎不活化ワクチン 卸業者
• A型肝炎不活化ワクチン 顧客

第13章 A型肝炎不活化ワクチン 市場動向

• A型肝炎不活化ワクチン 業界動向
• A型肝炎不活化ワクチン 市場の促進要因
• A型肝炎不活化ワクチン 市場の課題
• A型肝炎不活化ワクチン 市場の抑制要因

第14章 主な調査結果 世界のA型肝炎不活化ワクチンの主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 25U/0.5ml

Table 3. Major Manufacturers of 50U/1.0ml

Table 4. Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Hepatitis A Inactivated Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Hepatitis A Inactivated Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Hepatitis A Inactivated Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2019-2024)

Table 9. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2025-2030)

Table 10. Global Hepatitis A Inactivated Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (L)

Table 11. Global Hepatitis A Inactivated Vaccine Sales by Region (2019-2024) & (L)

Table 12. Global Hepatitis A Inactivated Vaccine Sales by Region (2025-2030) & (L)

Table 13. Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2019-2024)

Table 14. Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2025-2030)

Table 15. Global Hepatitis A Inactivated Vaccine Sales by Manufacturers (2019-2024) & (L)

Table 16. Global Hepatitis A Inactivated Vaccine Sales Share by Manufacturers (2019-2024)

Table 17. Global Hepatitis A Inactivated Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Hepatitis A Inactivated Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Hepatitis A Inactivated Vaccine Price by Manufacturers (2019-2024) & (US$/L)

Table 21. Global Hepatitis A Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Hepatitis A Inactivated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Inactivated Vaccine as of 2023)

Table 23. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Product Offered and Application

Table 25. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 28. Global Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 29. Global Hepatitis A Inactivated Vaccine Sales Share by Type (2019-2024)

Table 30. Global Hepatitis A Inactivated Vaccine Sales Share by Type (2025-2030)

Table 31. Global Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Hepatitis A Inactivated Vaccine Revenue Share by Type (2019-2024)

Table 34. Global Hepatitis A Inactivated Vaccine Revenue Share by Type (2025-2030)

Table 35. Hepatitis A Inactivated Vaccine Price by Type (2019-2024) & (US$/L)

Table 36. Global Hepatitis A Inactivated Vaccine Price Forecast by Type (2025-2030) & (US$/L)

Table 37. Global Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 38. Global Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 39. Global Hepatitis A Inactivated Vaccine Sales Share by Application (2019-2024)

Table 40. Global Hepatitis A Inactivated Vaccine Sales Share by Application (2025-2030)

Table 41. Global Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Hepatitis A Inactivated Vaccine Revenue Share by Application (2019-2024)

Table 44. Global Hepatitis A Inactivated Vaccine Revenue Share by Application (2025-2030)

Table 45. Hepatitis A Inactivated Vaccine Price by Application (2019-2024) & (US$/L)

Table 46. Global Hepatitis A Inactivated Vaccine Price Forecast by Application (2025-2030) & (US$/L)

Table 47. US & Canada Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 48. US & Canada Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 49. US & Canada Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 52. US & Canada Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 53. US & Canada Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Hepatitis A Inactivated Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Hepatitis A Inactivated Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Hepatitis A Inactivated Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Hepatitis A Inactivated Vaccine Sales by Country (2019-2024) & (L)

Table 59. US & Canada Hepatitis A Inactivated Vaccine Sales by Country (2025-2030) & (L)

Table 60. Europe Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 61. Europe Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 62. Europe Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 65. Europe Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 66. Europe Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Hepatitis A Inactivated Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Hepatitis A Inactivated Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Hepatitis A Inactivated Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Hepatitis A Inactivated Vaccine Sales by Country (2019-2024) & (L)

Table 72. Europe Hepatitis A Inactivated Vaccine Sales by Country (2025-2030) & (L)

Table 73. China Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 74. China Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 75. China Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 78. China Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 79. China Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 82. Asia Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 83. Asia Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 86. Asia Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 87. Asia Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Hepatitis A Inactivated Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Hepatitis A Inactivated Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Hepatitis A Inactivated Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Hepatitis A Inactivated Vaccine Sales by Region (2019-2024) & (L)

Table 93. Asia Hepatitis A Inactivated Vaccine Sales by Region (2025-2030) & (L)

Table 94. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Type (2019-2024) & (L)

Table 95. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Type (2025-2030) & (L)

Table 96. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Application (2019-2024) & (L)

Table 99. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Application (2025-2030) & (L)

Table 100. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Country (2019-2024) & (L)

Table 106. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Country (2025-2030) & (L)

Table 107. Pfizer Company Information

Table 108. Pfizer Description and Major Businesses

Table 109. Pfizer Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 110. Pfizer Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Pfizer Recent Developments

Table 112. Merck Company Information

Table 113. Merck Description and Major Businesses

Table 114. Merck Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 115. Merck Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Merck Recent Developments

Table 117. Sanofi Company Information

Table 118. Sanofi Description and Major Businesses

Table 119. Sanofi Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 120. Sanofi Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Sanofi Recent Developments

Table 122. GlaxoSmithKline Company Information

Table 123. GlaxoSmithKline Description and Major Businesses

Table 124. GlaxoSmithKline Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 125. GlaxoSmithKline Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. GlaxoSmithKline Recent Developments

Table 127. Health Pharma Company Information

Table 128. Health Pharma Description and Major Businesses

Table 129. Health Pharma Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 130. Health Pharma Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Health Pharma Recent Developments

Table 132. Huakang Pharmaceutical Company Information

Table 133. Huakang Pharmaceutical Description and Major Businesses

Table 134. Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 135. Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Huakang Pharmaceutical Recent Developments

Table 137. Limin Pharmaceutical Company Information

Table 138. Limin Pharmaceutical Description and Major Businesses

Table 139. Limin Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 140. Limin Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Limin Pharmaceutical Recent Developments

Table 142. Xianghe Pharmaceutical Company Information

Table 143. Xianghe Pharmaceutical Description and Major Businesses

Table 144. Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 145. Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Xianghe Pharmaceutical Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Hepatitis A Inactivated Vaccine Distributors List

Table 150. Hepatitis A Inactivated Vaccine Customers List

Table 151. Hepatitis A Inactivated Vaccine Market Trends

Table 152. Hepatitis A Inactivated Vaccine Market Drivers

Table 153. Hepatitis A Inactivated Vaccine Market Challenges

Table 154. Hepatitis A Inactivated Vaccine Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Hepatitis A Inactivated Vaccine Product Picture

Figure 2. Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hepatitis A Inactivated Vaccine Market Share by Type: 2023 & 2030

Figure 4. 25U/0.5ml Product Picture

Figure 5. 50U/1.0ml Product Picture

Figure 6. Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Hepatitis A Inactivated Vaccine Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Hepatitis A Inactivated Vaccine Report Years Considered

Figure 12. Global Hepatitis A Inactivated Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 14. Global Hepatitis A Inactivated Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2019-2030)

Figure 17. Global Hepatitis A Inactivated Vaccine Sales (2019-2030) & (L)

Figure 18. Global Hepatitis A Inactivated Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (L)

Figure 19. Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Hepatitis A Inactivated Vaccine Sales YoY (2019-2030) & (L)

Figure 21. US & Canada Hepatitis A Inactivated Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Hepatitis A Inactivated Vaccine Sales YoY (2019-2030) & (L)

Figure 23. Europe Hepatitis A Inactivated Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Hepatitis A Inactivated Vaccine Sales YoY (2019-2030) & (L)

Figure 25. China Hepatitis A Inactivated Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Hepatitis A Inactivated Vaccine Sales YoY (2019-2030) & (L)

Figure 27. Asia (excluding China) Hepatitis A Inactivated Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales YoY (2019-2030) & (L)

Figure 29. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Hepatitis A Inactivated Vaccine Sales Share by Manufacturers (2023)

Figure 31. The Hepatitis A Inactivated Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Hepatitis A Inactivated Vaccine Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Hepatitis A Inactivated Vaccine in the World: Market Share by Hepatitis A Inactivated Vaccine Revenue in 2023

Figure 34. Global Hepatitis A Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 36. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 37. Global Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 38. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Hepatitis A Inactivated Vaccine Revenue Share by Country (2019-2030)

Figure 44. US & Canada Hepatitis A Inactivated Vaccine Sales Share by Country (2019-2030)

Figure 45. US Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 48. Europe Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 49. Europe Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 50. Europe Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 51. Europe Hepatitis A Inactivated Vaccine Revenue Share by Country (2019-2030)

Figure 52. Europe Hepatitis A Inactivated Vaccine Sales Share by Country (2019-2030)

Figure 53. Germany Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. France Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 58. China Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 59. China Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 60. China Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 61. China Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 62. Asia Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 63. Asia Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 64. Asia Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 65. Asia Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 66. Asia Hepatitis A Inactivated Vaccine Revenue Share by Region (2019-2030)

Figure 67. Asia Hepatitis A Inactivated Vaccine Sales Share by Region (2019-2030)

Figure 68. Japan Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 72. India Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales Share by Country (2019-2030)

Figure 80. Brazil Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Hepatitis A Inactivated Vaccine Revenue (2019-2030) & (US$ Million)

Figure 85. Hepatitis A Inactivated Vaccine Value Chain

Figure 86. Hepatitis A Inactivated Vaccine Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

This research report focuses on the Hepatitis A Inactivated Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Hepatitis A Inactivated Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 25U/0.5ml
  • 1.2.3 50U/1.0ml
• 1.3 Market by Application
  • 1.3.1 Global Hepatitis A Inactivated Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Hepatitis A Inactivated Vaccine Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Hepatitis A Inactivated Vaccine Revenue by Region
  • 2.2.1 Global Hepatitis A Inactivated Vaccine Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Hepatitis A Inactivated Vaccine Revenue by Region (2019-2024)
  • 2.2.3 Global Hepatitis A Inactivated Vaccine Revenue by Region (2025-2030)
  • 2.2.4 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2019-2030)
• 2.3 Global Hepatitis A Inactivated Vaccine Sales Estimates and Forecasts 2019-2030
• 2.4 Global Hepatitis A Inactivated Vaccine Sales by Region
  • 2.4.1 Global Hepatitis A Inactivated Vaccine Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Hepatitis A Inactivated Vaccine Sales by Region (2019-2024)
  • 2.4.3 Global Hepatitis A Inactivated Vaccine Sales by Region (2025-2030)
  • 2.4.4 Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Hepatitis A Inactivated Vaccine Sales by Manufacturers
  • 3.1.1 Global Hepatitis A Inactivated Vaccine Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Hepatitis A Inactivated Vaccine Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis A Inactivated Vaccine in 2023
• 3.2 Global Hepatitis A Inactivated Vaccine Revenue by Manufacturers
  • 3.2.1 Global Hepatitis A Inactivated Vaccine Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A Inactivated Vaccine Revenue in 2023
• 3.3 Global Key Players of Hepatitis A Inactivated Vaccine, Industry Ranking, 2021 VS 2022
• 3.4 Global Hepatitis A Inactivated Vaccine Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Hepatitis A Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Product Offered and Application
• 3.8 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Hepatitis A Inactivated Vaccine Sales by Type
  • 4.1.1 Global Hepatitis A Inactivated Vaccine Historical Sales by Type (2019-2024)
  • 4.1.2 Global Hepatitis A Inactivated Vaccine Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Hepatitis A Inactivated Vaccine Sales Market Share by Type (2019-2030)
• 4.2 Global Hepatitis A Inactivated Vaccine Revenue by Type
  • 4.2.1 Global Hepatitis A Inactivated Vaccine Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Hepatitis A Inactivated Vaccine Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2019-2030)
• 4.3 Global Hepatitis A Inactivated Vaccine Price by Type
  • 4.3.1 Global Hepatitis A Inactivated Vaccine Price by Type (2019-2024)
  • 4.3.2 Global Hepatitis A Inactivated Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Hepatitis A Inactivated Vaccine Sales by Application
  • 5.1.1 Global Hepatitis A Inactivated Vaccine Historical Sales by Application (2019-2024)
  • 5.1.2 Global Hepatitis A Inactivated Vaccine Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Hepatitis A Inactivated Vaccine Sales Market Share by Application (2019-2030)
• 5.2 Global Hepatitis A Inactivated Vaccine Revenue by Application
  • 5.2.1 Global Hepatitis A Inactivated Vaccine Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Hepatitis A Inactivated Vaccine Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2019-2030)
• 5.3 Global Hepatitis A Inactivated Vaccine Price by Application
  • 5.3.1 Global Hepatitis A Inactivated Vaccine Price by Application (2019-2024)
  • 5.3.2 Global Hepatitis A Inactivated Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Hepatitis A Inactivated Vaccine Market Size by Type
  • 6.1.1 US & Canada Hepatitis A Inactivated Vaccine Sales by Type (2019-2030)
  • 6.1.2 US & Canada Hepatitis A Inactivated Vaccine Revenue by Type (2019-2030)
• 6.2 US & Canada Hepatitis A Inactivated Vaccine Market Size by Application
  • 6.2.1 US & Canada Hepatitis A Inactivated Vaccine Sales by Application (2019-2030)
  • 6.2.2 US & Canada Hepatitis A Inactivated Vaccine Revenue by Application (2019-2030)
• 6.3 US & Canada Hepatitis A Inactivated Vaccine Market Size by Country
  • 6.3.1 US & Canada Hepatitis A Inactivated Vaccine Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Hepatitis A Inactivated Vaccine Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Hepatitis A Inactivated Vaccine Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Hepatitis A Inactivated Vaccine Market Size by Type
  • 7.1.1 Europe Hepatitis A Inactivated Vaccine Sales by Type (2019-2030)
  • 7.1.2 Europe Hepatitis A Inactivated Vaccine Revenue by Type (2019-2030)
• 7.2 Europe Hepatitis A Inactivated Vaccine Market Size by Application
  • 7.2.1 Europe Hepatitis A Inactivated Vaccine Sales by Application (2019-2030)
  • 7.2.2 Europe Hepatitis A Inactivated Vaccine Revenue by Application (2019-2030)
• 7.3 Europe Hepatitis A Inactivated Vaccine Market Size by Country
  • 7.3.1 Europe Hepatitis A Inactivated Vaccine Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Hepatitis A Inactivated Vaccine Revenue by Country (2019-2030)
  • 7.3.3 Europe Hepatitis A Inactivated Vaccine Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Hepatitis A Inactivated Vaccine Market Size by Type
  • 8.1.1 China Hepatitis A Inactivated Vaccine Sales by Type (2019-2030)
  • 8.1.2 China Hepatitis A Inactivated Vaccine Revenue by Type (2019-2030)
• 8.2 China Hepatitis A Inactivated Vaccine Market Size by Application
  • 8.2.1 China Hepatitis A Inactivated Vaccine Sales by Application (2019-2030)
  • 8.2.2 China Hepatitis A Inactivated Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Hepatitis A Inactivated Vaccine Market Size by Type
  • 9.1.1 Asia Hepatitis A Inactivated Vaccine Sales by Type (2019-2030)
  • 9.1.2 Asia Hepatitis A Inactivated Vaccine Revenue by Type (2019-2030)
• 9.2 Asia Hepatitis A Inactivated Vaccine Market Size by Application
  • 9.2.1 Asia Hepatitis A Inactivated Vaccine Sales by Application (2019-2030)
  • 9.2.2 Asia Hepatitis A Inactivated Vaccine Revenue by Application (2019-2030)
• 9.3 Asia Hepatitis A Inactivated Vaccine Market Size by Region
  • 9.3.1 Asia Hepatitis A Inactivated Vaccine Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Hepatitis A Inactivated Vaccine Revenue by Region (2019-2030)
  • 9.3.3 Asia Hepatitis A Inactivated Vaccine Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Hepatitis A Inactivated Vaccine Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Information
  • 11.1.2 Pfizer Overview
  • 11.1.3 Pfizer Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Pfizer Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Pfizer Recent Developments
• 11.2 Merck
  • 11.2.1 Merck Company Information
  • 11.2.2 Merck Overview
  • 11.2.3 Merck Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Merck Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merck Recent Developments
• 11.3 Sanofi
  • 11.3.1 Sanofi Company Information
  • 11.3.2 Sanofi Overview
  • 11.3.3 Sanofi Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Sanofi Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sanofi Recent Developments
• 11.4 GlaxoSmithKline
  • 11.4.1 GlaxoSmithKline Company Information
  • 11.4.2 GlaxoSmithKline Overview
  • 11.4.3 GlaxoSmithKline Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 GlaxoSmithKline Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 GlaxoSmithKline Recent Developments
• 11.5 Health Pharma
  • 11.5.1 Health Pharma Company Information
  • 11.5.2 Health Pharma Overview
  • 11.5.3 Health Pharma Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Health Pharma Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Health Pharma Recent Developments
• 11.6 Huakang Pharmaceutical
  • 11.6.1 Huakang Pharmaceutical Company Information
  • 11.6.2 Huakang Pharmaceutical Overview
  • 11.6.3 Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Huakang Pharmaceutical Recent Developments
• 11.7 Limin Pharmaceutical
  • 11.7.1 Limin Pharmaceutical Company Information
  • 11.7.2 Limin Pharmaceutical Overview
  • 11.7.3 Limin Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Limin Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Limin Pharmaceutical Recent Developments
• 11.8 Xianghe Pharmaceutical
  • 11.8.1 Xianghe Pharmaceutical Company Information
  • 11.8.2 Xianghe Pharmaceutical Overview
  • 11.8.3 Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Xianghe Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Hepatitis A Inactivated Vaccine Industry Chain Analysis
• 12.2 Hepatitis A Inactivated Vaccine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Hepatitis A Inactivated Vaccine Production Mode & Process
• 12.4 Hepatitis A Inactivated Vaccine Sales and Marketing
  • 12.4.1 Hepatitis A Inactivated Vaccine Sales Channels
  • 12.4.2 Hepatitis A Inactivated Vaccine Distributors
• 12.5 Hepatitis A Inactivated Vaccine Customers

13 Hepatitis A Inactivated Vaccine Market Dynamics

• 13.1 Hepatitis A Inactivated Vaccine Industry Trends
• 13.2 Hepatitis A Inactivated Vaccine Market Drivers
• 13.3 Hepatitis A Inactivated Vaccine Market Challenges
• 13.4 Hepatitis A Inactivated Vaccine Market Restraints

14 Key Findings in the Global Hepatitis A Inactivated Vaccine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer